Quick Answer
Clearside Biomedical, Inc. reported Total Revenue of $1.66 million for the year ending 2024.
- Clearside Biomedical, Inc. showed a decrease of -79.8% in Total Revenue from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $130.0 thousand | Q3 2017: $155.0 thousand | Q1 2019: $45.0 thousand | Q2 2019: $45.0 thousand | Q3 2019: $141.0 thousand | Q1 2020: $4.10 million | Q2 2020: $354.0 thousand | Q3 2020: $3.43 million | Q1 2021: $34.0 thousand | Q2 2021: $780.0 thousand | Q3 2021: $3.07 million | Q1 2022: $347.0 thousand | Q2 2022: $384.0 thousand | Q3 2022: $266.0 thousand | Q1 2023: $4.0 thousand | Q2 2023: $1.02 million | Q3 2023: $859.0 thousand | Q1 2024: $230.0 thousand | Q2 2024: $90.0 thousand | Q3 2024: $1.04 million | Q1 2025: $2.33 million | Q2 2025: $492.0 thousand | Q3 2025: $201.0 thousand.
- Over the full 9 years of available data (2016 to 2024), Clearside Biomedical, Inc.'s Total Revenue has grown by 220.0%.
- Historical annual values: Fiscal year 2024: $1.66 million | Fiscal year 2023: $8.23 million | Fiscal year 2022: $1.33 million | Fiscal year 2021: $29.58 million | Fiscal year 2020: $7.89 million | Fiscal year 2019: $2.17 million | Fiscal year 2018: $30.0 thousand | Fiscal year 2017: $345.0 thousand | Fiscal year 2016: $520.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: